期刊文献+

306株铜绿假单胞菌的耐药性分析 被引量:1

下载PDF
导出
摘要 目的:分析铜绿假单胞菌耐药现状,为临床预防感染及合理选择抗菌药物提供依据。方法:对2005年1月.2006年12月我院住院患者标本按常规方法培养后,经ATB Expression细菌鉴定仪鉴定,用kitty—Bauer法进行药物敏感试验,按NCCLS标准判断。结果:铜绿假单胞菌对12种抗菌药物的耐药率较低的是含酶抑制剂复合药及碳青酶烯类,最低的是美罗培南(18.6%),其次是派拉西林/他唑巴坦(19.0%)、头孢哌酮/舒巴坦(22.2%)、亚胺培南(40.2%)。对其它各类抗菌药物的耐药率均大于50%.结论:本院铜绿假单胞菌以呼吸道感染为主,且耐药情况较严重,应该合理选用抗菌药物,以减少耐药菌株的出现与传播。
出处 《中国民康医学》 2007年第24期1133-1133,1138,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献5

二级参考文献44

  • 1张国伟,明德松,吴一波.4种酶抑制剂分类检测碳青酶烯酶的研究[J].中华医院感染学杂志,2004,14(10):1098-1099. 被引量:6
  • 2吴蓉,府伟灵.重庆地区铜绿假单胞菌医院感染及耐药性分析[J].中华医院感染学杂志,2004,14(1):97-99. 被引量:143
  • 3吴礼襄,萧正伦,黎毅敏.MRSA呼吸系统医院感染的分子流行病学调查[J].中华医院感染学杂志,2004,14(4):453-457. 被引量:76
  • 4Okamoto K, Gotoh N, Nishino T. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay [J]. Antimicrob Agents Chemother, 2001,45(7): 1964-1971.
  • 5National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests[S].M100-S9,NCCLS,1999.1-103.
  • 6Ochs M M, McCusker M P, Bains M, et al. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids [J]. Antimicrob Agents Chemother,1999,43(5): 1085-1090.
  • 7Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds [J]. J Clin Microbiol,2000, 38: 40-43.
  • 8Bustamante CI, Wharton RC, Wade JC. In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolate of Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother,1990,34(9):1814-1815.
  • 9Dudley M N, Blaser J, Gilber D, et al. Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa : effect of simultaneous versus staggered administration in an in vitro model of infection[J]. J Infect Dis, 1991,164(3):499-506.
  • 10Klepser ME, Patel KB, Nicolau DP, et al. Comparison of bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 19

共引文献206

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部